| 查看: 253 | 回复: 2 | |||
| 当前主题已经存档。 | |||
[交流]
Cracking the GRE Biology, 3rd Edition
|
|||
|
Cracking the GRE Biology, 3rd Edition by Deborah Guest 352 pages Princeton Review The Princeton Review doesn't try to teach students everything there is to know about biology -- only what they'll need to know to score higher on the GRE Biology. There's a big difference. In Cracking the GRE Biology, TPR will teach test-takers how to think like the test-makers. This is accomplished by teaching students how to: Know what types of questions to expect Improve scores by studying the topics most likely to appear on the test Sharpen skills in TPR's biology lab Get ahead with Word Watch, TPR's list of terms that frequently appear on the test *This book includes a full-length simulated GRE Biology test. All of The Princeton Review's sample test questions are like the ones test-takers will see on the actual GRE Biology test, and every solution is fully explained. Contents Include: Part I: Introduction Part II: Cell and Molecular Biology Remember Organic Chemistry? The Eukaryotic Cell Cellular Energetics DNA, RNA, Transcription, and Translation Cell Division: Mitosis and Meiosis Fertilization and Development Microorganisms: Bacteria, Fungi, and Viruses Part III: Human Physiology The Circulatory System The Digestive System The Excretory System The Endocrine System The Musculoskeletal System The Nervous System The Respiratory System Part IV: Organismal Biology Plants Genetics and Evolution Ecology and Animal Behavior Part V: GRE Biology Lab Part VI: Word Watch Part VII: TPR Diagnostic Test Part VIII: Explanations Download Link: http://rapidshare.de/files/9509018/Cracking_gre.zip.html |
» 猜你喜欢
膀胱癌靶向治疗新选择:厄达替尼作用机制与耐药研究进展
已经有0人回复
从水母到实验室:腔肠素的发现历程与生物发光奥秘
已经有1人回复
化学工程及工业化学论文润色/翻译怎么收费?
已经有282人回复
线粒体氧化磷酸化的新靶点:S-Gboxin的发现与研究进展
已经有0人回复
PROTAC药物开发选择VHL配体:MDK-7526以87%出口向量占有率成首选
已经有0人回复
MCC950:NLRP3炎症小体特异性抑制剂的科研应用与前景
已经有0人回复
康替唑胺研发17年:如何解决多重耐药菌感染难题
已经有0人回复
伊曲莫德(Etrasimod)从“肠道免疫失控”到精准靶向干预
已经有1人回复
西达本胺:创新HDAC抑制剂的抗肿瘤之路
已经有0人回复
金色抗生素单硫酸卡那霉素的物化性质、制备与前景
已经有0人回复

0.5
|
2楼2006-04-17 12:44:37
3楼2006-04-17 12:45:24











回复此楼